// App-Quantinova.ai

BSH19‐EP‐006 : Cyclin D1 G870A polymorphism and its relation to the risk of ALL development, prognosis and methotrexate cytotoxicity

Researchers

Presenter

  • A. Elmarghany

Principal Investigators

  • D. Aladle

  • N. Elmenshawy

  • M. Sarhan

Medical Centers

  • Clinical Pathology

  • Pediatrics, Mansoura Univeristy, Mansoura, Egypt

Locations

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cyclin D1

Drug/Treatment

  • Methotrexate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved